Evidence map›Paper›PMID 37892169›Full record

ArticleBiomolecules2023

Exploiting Differences in Heme Biosynthesis between Bacterial Species to Screen for Novel Antimicrobials.

Laurie K Jackson, Tammy A Dailey, Brenden Anderle, Martin J Warren, Hector A Bergonia, Harry A Dailey, John D Phillips

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Laurie K JacksonDepartment of Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT 84112, USA.
Tammy A DaileyDepartment of Microbiology, Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Brenden AnderleWhiteTree Medical, 10437 S Jordan Gateway, South Jordan, UT 84095, USA.
Martin J WarrenQuadram Institute Bioscience, Norwich Research Park, Norwich NR4 7UQ, UK.
Hector A BergoniaDepartment of Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT 84112, USA.
Harry A DaileyDepartment of Microbiology, Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
John D PhillipsDepartment of Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT 84112, USA.
University of Utah · USUniversity of Georgia · USQuadram Institute · GB

Funding

Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6M
PORPHYRIN BIOSYNTHESIS IN NORMAL AND DISEASE STATESR01DK020503 · NIDDK · UNIVERSITY OF UTAH · PI PARKER, CHARLES J, PHILLIPS, JOHN DEARBORN · 1986 to 2012
$3.3M
Erythroid heme synthesis regulation via the ferrochelatase [2Fe-2S] clusterR01DK096051 · NIDDK · UNIVERSITY OF GEORGIA · PI DAILEY, HARRY A · 2012 to 2015
$1.5M
PORPHYRIN BIOSYNTHESIS IN NORMAL AND DISEASE STATESR37DK020503 · NIDDK · UNIVERSITY OF UTAH · PI KUSHNER, JAMES P · 1993 to 2001
$463k
Porphyrin Biosynthesis in Normal and Disease StatesR56DK020503 · NIDDK · UNIVERSITY OF UTAH · PI PHILLIPS, JOHN DEARBORN · 2013 to 2013
$149k
Biotechnology and Biological Sciences Research Council BBS/E/F/000PR13631Biotechnology and Biological Sciences Research Council BB/X011054/1NIDDK NIH HHS DK20503, DK110858, DK096051NIDDK NIH HHS R01 DK096051NIDDK NIH HHS U54 DK110858
6 · The paper itself

Abstract

The final three steps of heme biogenesis exhibit notable differences between di- and mono-derm bacteria. The former employs the protoporphyrin-dependent (PPD) pathway, while the latter utilizes the more recently uncovered coproporphyrin-dependent (CPD) pathway. In order to devise a rapid screen for potential inhibitors that differentiate the two pathways, the genes associated with the protoporphyrin pathway in an

Indexed as

Escherichia coliProtoporphyrinsBacteriaHemeHemeProtoporphyrinsantimicrobialdidermheme biosynthesismonodermscreen

Identifiers

PMID37892169
PMCPMC10604556
OpenAlexW4387420025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.